A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity
Authors
Christopher Jackson (ORCID: https://orcid.org/0000-0001-6150-709X)
David Porter (ORCID: https://orcid.org/0000-0002-3115-8244)
Sarah Benge (ORCID: https://orcid.org/0000-0002-2331-4593)
A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity
Christopher Jackson, David Porter, Sarah Benge, Richard North et al.
Journal
Cancer Chemotherapy and Pharmacology
Topics
Colorectal Cancer Treatments and Studies
article
A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity
Christopher Jackson, David Porter, Sarah Benge, Richard North, Kathryn Elisa Burns, Ben M. Lawrence, Katrina Sharples, Sanjeev Deva, Michael Findlay, Soo Hee Jeong, Nuala A. Helsby, Yu Jin Kim, John A. Duley, Robert Matthew Strother
article en
Abstract
No abstract available for this paper.
Publication Tag
Cancer Chemotherapy and PharmacologyVol. 95(1)
Institutions
University of Auckland (NZ), The University of Queensland (AU), Auckland City Hospital (NZ), Dunedin Public Hospital (NZ), Christchurch Hospital (NZ), Tauranga Hospital (NZ), Cancer Society of New Zealand (NZ), Clinical Trials New Zealand (NZ), University of Otago (NZ)
Funders
University of Auckland
Sustainable Development Goals
Reduced inequalities, Peace, Justice and strong institutions